A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection

New England Journal of Medicine

Volumn 337, Issue 5, 1997, Pages 307-314

  Rolfs, Robert T ^a   Joesoef, M Riduan ^a   Hendershot, Edward F ^c   Rompalo, Anne M ^d   Augenbraun, Michael H ^e   Chiu, Michael ^f   Bolan, Gail ^g   Johnson, Steven C ^h   French, Pamela ^c   Steen, Eric ^f   Radolf, Justin D ^f   Larsen, Sandra ^b,h   Brady, William E ^a   Wagner, Kenneth F ^h   D'Aquilante, Debra A ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c PHILADELPHIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g S Francisco Dept of Public Health   (United States)

^h WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BENZATHINE PENICILLIN; PROBENECID;

ADULT; ARTICLE; CEREBROSPINAL FLUID EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROSYPHILIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYPHILIS; TREATMENT FAILURE; TREPONEMA PALLIDUM;

ADULT; AMOXICILLIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; MALE; PENICILLIN G, BENZATHINE; PENICILLINS; PROBENECID; SYPHILIS; SYPHILIS SERODIAGNOSIS; TREATMENT FAILURE; TREPONEMA PALLIDUM;

EID: 8544252402     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199707313370504     Document Type: Article

References (52)

1. Johns DR, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 1987;316:1569-72.
2. Berry CD, Hooton TM, Collier AC, Lukehart SA. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987;316:1587-9.
3. Musher DM, Hamill RJ, Baughn RE. Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Intern Med 1990;113:872-81.
4. Lanska MJ, Lanska DJ, Schmidley JW. Syphilitic polyradiculopathy in an HIV-positive man. Neurology 1988;38:1297-301.
5. Kase CS, Levitz SM, Wolinsky JS, Sulis CA. Pontine pure motor hemiparesis due to meningovascular syphilis in human immunodeficiency virus-positive patients. Arch Neurol 1988;45:832.
6. Feraru ER, Aronow HA, Lipton RB. Neurosyphilis in AIDS patients: initial CSF VDRL may be negative. Neurology 1990;40:541-3.
7. Graman PS, Trupei MA, Reichman RC. Evaluation of cerebrospinal fluid in asymptomatic late syphilis. Sex Transm Dis 1987;14:205-8.
8. Lukehart SA, Hook EW III, Baker-Zander SA, Collier AC, Critchlow CW, Handsfield HH. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988; 109:855-62.
9. Musher DM. How much penicillin cures early syphilis? Ann Intern Med 1988;109:849-51.
10. Tramont EC. Syphilis in the AIDS era. N Engl J Med 1987;316:1600-1.
11. Recommendations for diagnosing and treating syphilis in HIV-infected patients. MMWR Morb Mortal Wkly Rep 1988;37:600-2, 607-8.
12. Fiumara NJ. Treatment of seropositive primary syphilis: an evaluation of 196 patients. Sex Transm Dis 1977;4:92-5.
13. Byrne TN, Bose A, Sze G, Waxman SG. Syphilitic meningitis causing paraparesis in an HIV-negative woman. J Neurol Sci 1991;103:48-50.
14. Chemouilli P, Amarenco P, Roullet E, Marteau R. Neurosyphilis tardive: maladie d'actualité. Rev Med Interne 1989;10:503-8.
15. Tramont EC. Persistence of Treponema pallidum following penicillin G therapy: report of two cases. JAMA 1976;236:2206-7.
16. Hira SK, Patel JS, Bhat SG, Chilikima K, Mooney N. Clinical manifestations of secondary syphilis. Int J Dermatol 1987;26:103-7.
17. Hook EW III. Management of syphilis in human immunodeficiency virus-infected patients. Am J Med 1992;93:477-9.
18. Zenker PN, Rolfs RT. Treatment of syphilis, 1989. Rev Infect Dis 1990;12:Suppl 6:S590-S609.
19. Yoder FW. Penicillin treatment of neurosyphilis: are recommended dosages sufficient? JAMA 1975;232:270-1.
20. Ducas J, Robson HG. Cerebrospinal fluid penicillin levels during therapy for latent syphilis. JAMA 1981;246:2583-4.
21. Mohr JA, Griffiths W, Jackson R, Saadah H, Bird P, Riddle J. Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA 1976;236:2208-9.
22. Polnikorn N, Witoonpanich R, Vorachit M, Vejjajiva S, Vejjajiva A. Penicillin concentrations in cerebrospinal fluid after different treatment regimens for syphilis. Br J Vener Dis 1980;56:363-7.
23. Morrison RE, Harrison SM, Tramont EC. Oral amoxycillin, an alternate treatment for neurosyphilis. Genitourin Med 1985;61:359-62.
24. Faber WR, Bos JD, Rietra PJGM, Fass H, Van Eijk RVW. Treponemicidal levels of amoxicillin in cerebrospinal fluid after oral administration. Sex Transm Dis 1983;10:148-50.
25. Larsen SA, Hunter EF, Kraus SJ, eds. A manual of tests for syphilis. 8th ed. Washington, D.C.: American Public Health Association, 1990.
26. Update: serologic testing for antibody to human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1988;36:833-40, 845.
27. Kidd PG, Vogt RF Jr. Report of the workshop on the evaluation of T-cell subsets during HIV infection and AIDS. Clin Immunol Immunopathol 1989;52:3-9.
28. Landay AL, Muirhead KA. Procedural guidelines for performing immunophenotyping by flow cytometry. Clin Immunol Immunopathol 1989;52:48-60.
29. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41(RR-17):1-19.
30. Sánchez PJ, Wendel GD Jr, Grimprel E, et al. Evaluation of molecular methodologies and rabbit infectivity testing for the diagnosis of congenital syphilis and neonatal central nervous system invasion by Treponema pallidum. J Infect Dis 1993;167:148-57.
31. Radolf JD. PCR detection of Treponema pallidum. In: Persing DH, Smith TF, Tenover FC, White TJ, eds. Diagnostic molecular microbiology: principles and applications. Washington, D.C.: American Society for Microbiology, 1993:224-9.
32. Weigel LM, Brandt ME, Norgard MV. Analysis of the N-terminal region of the 47-kilodalton integral membrane lipoprotein of Treponema pallidum. Infect Immun 1992;60:1568-76.
33. Hsu P-L, Chamberlain NR, Orth K, et al. Sequence analysis of the 47-kilodalton major integral membrane immunogen of Treponema pallidum. Infect Immun 1989;57:196-203.
34. Akins DR, Purcell BK, Mitra MM, Norgard MV, Radolf JD. Lipid modification of the 17-kilodalton membrane immunogen of Treponema pallidum determines macrophage activation as well as amphiphilicity. Infect Immun 1993;61:1202-10.
35. Altman DG. Practical statistics for medical research. London: Chapman & Hall, 1991.
36. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS system for mixed model. Cary, N.C.: SAS Institute, 1996:87-134.
37. Zeger SL, Liang K-Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
38. Hutchinson CM, Hook EW III, Shepherd M, Verley J, Rompalo AM. Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med 1994;121:94-100.
39. Gourevitch MN, Selwyn PA, Davenny K, et al. Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med 1993;118:350-5.
40. Telzak EE, Greenberg MS, Harrison J, Stoneburner RL, Schultz S. Syphilis treatment response in HIV-infected individuals. AIDS 1991;5:591-5.
41. Yinnon AM, Coury-Doniger P, Polito R, Reichman RC. Serologic response to treatment of syphilis in patients with HIV infection. Arch Intern Med 1996;156:321-5.
42. Brown ST, Zaidi A, Larsen SA, Reynolds GH. Serological response to syphilis treatment: a new analysis of old data. JAMA 1985;253:1296-9.
43. Guinan ME. Treatment of primary and secondary syphilis: defining failure at three- and six-month follow-up. JAMA 1987;257:359-60.
44. Schroeter AL, Lucas JB, Price EV, Falcone VH. Treatment for early syphilis and reactivity of serologic tests. JAMA 1972;221:471-6.
45. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983;309:453-8.
46. Goodman SN, Berlin JA. The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann Intern Med 1994;121:200-6. [Erratum, Ann Intern Med 1995; 122:4781.]
47. Schulz KF. Subverting randomization in controlled trials. JAMA 1995; 274:1456-8.
48. Dowell ME, Ross PG, Musher DM, Cate TR, Baughn RE. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 1992;93:481-8.
49. Gordon SM, Eaton ME, George R, et al. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med 1994;331:1469-73.
50. Rolfs RT. Treatment of syphilis, 1993. Clin Infect Dis 1995;20:Suppl 1:S23-S38.
51. 1993 Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 1993;42(RR-14).
52. Romanowski B, Sutherland R, Fick GH, Mooney D, Love EJ. Serologic response to treatment of infectious syphilis. Ann Intern Med 1991; 114:1005-9.